Herbrecht R - Search Results

1

Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.

Santucci R, Levêque D, Lescoute A, Kemmel V, Herbrecht R. Santucci R, et al. Among authors: herbrecht r. Anticancer Res. 2010 Sep;30(9):3807-10. Anticancer Res. 2010. PMID: 20944174

2

Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.

Jarfaut A, Santucci R, Levêque D, Herbrecht R. Jarfaut A, et al. Among authors: herbrecht r. Med Mal Infect. 2013 Jan;43(1):39-41. doi: 10.1016/j.medmal.2012.11.006. Epub 2013 Jan 14. Med Mal Infect. 2013. PMID: 23332768 No abstract available.

3

[Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients].

Santucci R, Levêque D, Herbrecht R, Fischbach M, Gérout AC, Untereiner C, Bouayad-Agha K, Couturier F. Santucci R, et al. Among authors: herbrecht r. Ann Pharm Fr. 2014 Nov;72(6):440-50. doi: 10.1016/j.pharma.2014.05.003. Epub 2014 Jul 8. Ann Pharm Fr. 2014. PMID: 25438655 French.

4

[Erratum to "Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients" [Ann. Pharm. Fr. 72 (2014) 440-450].].

Santucci R, Levêque D, Herbrecht R, Fischbach M, Gérout AC, Untereiner C, Bouayad-Agha K, Couturier F. Santucci R, et al. Among authors: herbrecht r. Ann Pharm Fr. 2015 Jan 8;73(2):160-161. doi: 10.1016/j.pharma.2014.12.002. Online ahead of print. Ann Pharm Fr. 2015. PMID: 25578947 French. No abstract available.

5

Assessment of high-priced systemic antifungal prescriptions.

Poulat C, Nivoix Y, Launoy A, Lutun P, Bachellier P, Rohr S, Woehl ML, Levêque D, Bru V, Herbrecht R, Gourieux B. Poulat C, et al. Among authors: herbrecht r. Med Mal Infect. 2017 Oct;47(6):382-388. doi: 10.1016/j.medmal.2017.03.004. Epub 2017 Apr 13. Med Mal Infect. 2017. PMID: 28412043

6

Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.

Nivoix Y, Zamfir A, Lutun P, Kara F, Remy V, Lioure B, Rigolot JC, Entz-Werlé N, Letscher-Bru V, Waller J, Levêque D, Koffel JC, Beretz L, Herbrecht R. Nivoix Y, et al. Among authors: herbrecht r. J Infect. 2006 Jan;52(1):67-74. doi: 10.1016/j.jinf.2005.01.006. J Infect. 2006. PMID: 16368463

7

Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.

Herbrecht R, Damonte JC, Dufour P, Maloisel F, Liu KL, Ortiz S, Bergerat JP, Oberling F. Herbrecht R, et al. Semin Oncol. 1992 Feb;19(1 Suppl 1):7-10. Semin Oncol. 1992. PMID: 1384135

8

Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma after failure of the LNH 84 regimen.

Herbrecht R, Ortiz S, Damonte JC, Liu KL, Maloisel F, Dufour P, Bergerat JP, Oberling F. Herbrecht R, et al. Hematol Oncol. 1991 Jul-Oct;9(4-5):253-7. doi: 10.1002/hon.2900090411. Hematol Oncol. 1991. PMID: 1720760 Clinical Trial.

9

VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.

Herbrecht R, Garcia JJ, Bergerat JP, Dufour P, Duclos B, Oberling F. Herbrecht R, et al. Cancer Chemother Pharmacol. 1989;24(5):338-9. doi: 10.1007/BF00304770. Cancer Chemother Pharmacol. 1989. PMID: 2474382

10

[Results of cisplatin-based polychemotherapy and analysis of prognostic factors in ovarian cancer. Apropos of 106 cases].

Maloisel F, Dufour P, Bergerat JP, Bellocq JP, Duclos B, Boilletot A, Herbrecht R, Dellenbach P, Renaud R, Ritter P, et al. Maloisel F, et al. Among authors: herbrecht r. Bull Cancer. 1989;76(10):1083-93. Bull Cancer. 1989. PMID: 2635636 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page